Abiopharma

🔍 Cactus WH Enterprises, LLC (Executive)

Company: Cactus, Inc. (WHD)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Sold 100,000 shares of Class B Common Stock (Direct)
  Date: 2026-09-01 | Code: J | equity_swap_involved: 0 | shares_owned_after: 9,161,249.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 100,000 shares of Units (Derivative)
  Date: 2026-09-01 | Code: J | equity_swap_involved: 0 | shares_owned_after: 9,161,249.00 | transaction_form_type: 4 | Footnotes: F2, F3, F4, F4, F3, F4

Footnotes:

• F1: In connection with certain redemptions of ownership interests in the Reporting Entity by certain of the Reporting Entity's members pursuant to the amended and restated limited liability company operating agreement of the Reporting Entity, the Reporting Entity distributed Class B Common Stock to such members.
• F2: "Units" mean ownership interests in Cactus Companies, LLC ("Cactus Companies"). The Issuer is the sole managing member of Cactus Companies.
• F3: The amended and restated limited liability company operating agreement of Cactus Companies provides the holders of Units with certain rights to cause Cactus Companies to acquire all or at least a minimum portion of their Units for, at Cactus Companies election, (x) shares of Class A Common Stock at a redemption ratio of one share of Class A Common Stock for each Unit redeemed, subject to conversion rate adjustments for stock splits, stock dividends and reclassification and other similar transactions, or (y) an equivalent amount of cash.
• F4: In connection with certain redemptions of ownership interests in the Reporting Entity by certain of the Reporting Entity's members pursuant to the amended and restated limited liability company agreement of the Reporting Entity, the Reporting Entity distributed Units to such members.